FATE logo

FATE THERAPEUTICS INC

FATENASDAQ
🏆 #3013 by market capEarnings Oct 29US Equity
$2.74▼ $0.00 (−0.11%)
Live
1h▼ 0.3%
24h▼ 0.1%
7d▲ 5.9%
14d▲ 16.0%
30d▼ 9.4%
1y▲ 191.9%
🏦Market Cap
$319M
Small Cap
📈Revenue Growth (YoY)
-51.2%
Declining
📊Gross Margin
-415.8%
Thin
💵FCF Margin
-1711.4%
Thin
⚖️P/S Ratio
50.6x
Expensive
Otter Score
58
Weak
📊

Analyst Ratings

Price
$2.74
Total
31
Raised
2
Lowered
3
Avg PT
$5.50
H / L
$7 / $4
InstitutionActionRatingDate
HC Wainwright & Co.
ReiteratedBuy2026-06-08
Wedbush
UpgradedNeutral → Outperform2025-10-27
Needham
ReiteratedHold2025-10-27
Wells Fargo
ReiteratedEqual Weight2025-08-13
Baird
ReiteratedNeutral2025-05-14
Barclays
ReiteratedOverweight2025-05-14
Stifel
ReiteratedHold2025-03-06
Piper Sandler
UpgradedNeutral → Overweight2024-06-17
BMO Capital
ReiteratedMarket Perform2024-05-10
Canaccord Genuity
ReiteratedBuy2024-05-10
B of A Securities
ReiteratedUnderperform2024-03-28
Oppenheimer
ReiteratedPerform2024-02-27
Morgan Stanley
ReiteratedEqual Weight2024-02-27
Mizuho
ReiteratedBuy2023-11-20
Cantor Fitzgerald
ReiteratedNeutral2023-09-07
Truist Securities
ReiteratedHold2023-08-16
EF Hutton
ReiteratedBuy2023-08-09
Citigroup
ReiteratedBuy2023-03-02
Goldman Sachs
ReiteratedSell2023-01-09
SVB Leerink
ReiteratedOutperform2023-01-06
Cowen & Co.
DowngradedOutperform → Market Perform2023-01-06
Guggenheim
DowngradedBuy → Neutral2023-01-03
SunTrust Robinson Humphrey
ReiteratedBuy2019-11-12
Piper Jaffray
ReiteratedOverweight2019-09-16
BTIG
ReiteratedBuy2019-08-09
Roth Capital
ReiteratedNeutral2019-06-07
Jefferies
ReiteratedBuy2018-11-05
H.C. Wainwright
DowngradedBuy → Neutral2018-03-06
PiperJaffray
ReiteratedOverweight2017-12-18
Raymond James
ReiteratedOutperform2015-10-06
Leerink Swann
ReiteratedOutperform2015-06-01
One row per institution, most recent rating